Skip to Main Content

Advertisement

Skip Nav Destination

Therapeutic targeting of LCK tyrosine kinase and mTOR signaling in T-cell acute lymphoblastic leukemia

Blood (2022) 140 (17): 1891–1906.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement